Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Grünenthal Acquires Mestex AG and it's Phase-III-Ready Investigational Medicine MTX-071 for the Treatment of Pain Associated with Osteoarthritis of the Knee

americanpharmaceuticalreviewApril 13, 2021

Tag: grunenthal , Mestex AG , MTX-071 , osteoarthritis

PharmaSources Customer Service